Jabra Enhance has launched its next-generation M Series, a new lineup of three FDA-cleared self-fitting hearing aids: the Enhance Select M3, M2, and M1 . The flagship Enhance Select M3 is described by the company as the world’s smallest rechargeable micro receiver-in-ear (RIE) hearing aid and introduces Jabra Enhance’s latest speech and noise-management features....
Continue reading at Hearing Health Matters
✦ The floor
Discussion
Signed responses from readers of the wire.
No actionable change — this is a product launch announcement; audiologists should be aware of the new OTC competitor but no clinical guidance is implied.
The M Series expansion deepens Jabra's OTC portfolio with self-fitting technology and Auracast streaming, intensifying competition in the consumer hearing-aid market and further challenging traditional dispensing models.
- 01Jabra Enhance launched three FDA-cleared OTC self-fitting hearing aids: M1, M2, and M3.
- 02The flagship M3 is claimed to be the world's smallest rechargeable micro RIE (receiver-in-ear) device.
- 03All three models include self-tuning and Auracast Bluetooth LE Audio support.
- 04The lineup targets mild-to-moderate hearing loss without requiring professional fitting.
- 05OTC availability continues to pressure traditional clinic-dispensed hearing aid channels.
The Jabra Enhance M3 is the world's smallest rechargeable micro RIE hearing aid.
press releasepromotionalAll M Series devices are FDA-cleared self-fitting OTC hearing aids.
press releasesupportedM Series devices support Auracast Bluetooth LE Audio for wireless streaming.
press releasesupported